Lipopolysaccharides (LPS) anticorps

N° du produit ABIN479062

Détail du produit anti-Lipopolysaccharides (LPS) anticorps

Antigène: Lipopolysaccharides (LPS)

Reactivité: Bactérie à Gram négatif

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp Lipopolysaccharides (LPS) est non-conjugé

Application: Immunofluorescence (IF)

Specificité: Recognizes LPS. Cross-reactive with numerous members of the Enterobacteriaciae: Pseudomonas aeruginosa, Klebsiella pneumoniae, E. coli O157, Salmonella enteriditis, Enterobacter aerogenes, E. hermanii, Yersinia enterocolitica and Shigella sonnei.

Purification: Ion exchange chromatography

Immunogène: Whole cell prep of Lipid A from E. coli O157.

Type of Immunogen: Cells

Isotype: IgG

Information d'application

Indications d'application: Approved: IF

Usage: Suitable for use in Immunofluorescence. Tested with whole organisms in IF.

Commentaires:

Target Species of Antibody: Gram Negative Bacteria

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: PBS,  pH 7.2, 0.09 % sodium azide. No stabilizing proteins added.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: avoid freeze thaw cycles. Store undiluted.

Stock: 4 °C,-20 °C

Stockage commentaire: Short term 4°C, long term aliquot and store at -20°C, avoid freeze-thaw cycles. Store undiluted.

Références pour anticorps anti-Lipopolysaccharides (LPS) (ABIN479062)

Marconato, Tiraboschi, Aralla, Sabattini, Melacarne, Agnoli, Balboni, Salvi, Foglia, Punzi, Romagnoli, Rescigno: "A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy." dans: Cancers, Vol. 15, Issue 17, (2023) (PubMed).

Marconato, Melacarne, Aralla, Sabattini, Tiraboschi, Ferrari, Zeira, Balboni, Faroni, Guerra, Pisoni, Ghezzi, Pettinari, Rescigno: "A Target Animal Effectiveness Study on Adjuvant Peptide-Based Vaccination in Dogs with Non-Metastatic Appendicular Osteosarcoma Undergoing Amputation and Chemotherapy." dans: Cancers, Vol. 14, Issue 5, (2022) (PubMed).

Stromberg, Stromberg, Banisadr, Graves, Moxley, Mukundan: "Purification and characterization of lipopolysaccharides from six strains of non-O157 Shiga toxin-producing Escherichia coli." dans: Journal of microbiological methods, Vol. 116, pp. 1-7, (2015) (PubMed).

Zaborin, Defazio, Kade, Kaiser, Belogortseva, Camp, Smith, Adkins, Kim, Alverdy, Goldfeld, Firestone, Collier, Jabri, Tirrell, Zaborina, Alverdy: "Phosphate-containing polyethylene glycol polymers prevent lethal sepsis by multidrug-resistant pathogens." dans: Antimicrobial agents and chemotherapy, Vol. 58, Issue 2, pp. 966-77, (2014) (PubMed).

Détails sur Lipopolysaccharides (LPS)

Antigène: Lipopolysaccharides (LPS)

Autre désignation: Lipopolysaccharide / LPS (Lipopolysaccharides (LPS) Produits)

Classe de substances: Chemical

Sujet: Name/Gene ID: LPS

Synonyms: LPS